INDIANAPOLIS (Mirror Indy ... best known for introducing mass insulin production at Eli Lilly and Co. Woollen was 32 when he was chosen for the project. Because of his youth and relative inexperience, ...

INDIANAPOLIS (Mirror Indy ... best known for introducing mass insulin production at Eli Lilly and Co. Woollen was 32 when he was chosen for the project. Because of his youth and relative ...

Analysts expect the Indianapolis, Indiana-based company to report quarterly earnings at $5.08 per share, up from $2.49 per ...

Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of ...

Eli Lilly’s profit doubled in the fourth quarter ... States as a treatment for some forms of sleep apnea. For 2025, the Indianapolis drugmaker expects adjusted earnings to range between $ ...

With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global pharmaceutical firm renowned for its innovative contributions to healthcare.

Diabetes and Obesity Drugs Fuel Eli Lilly Profit in the Final Quarter ... analyst John Boylan said in a research note. For 2025, the Indianapolis drugmaker expects adjusted earnings to range ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

Eli Lilly has named Winselow Tucker as President and General Manager for India. Tucker will oversee operations, including the Lilly India commercial organization and the Lilly Capability Centre India.